KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) FCF Margin (2016 - 2025)

Historic FCF Margin for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to 14.88%.

  • Quest Diagnostics' FCF Margin rose 48300.0% to 14.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.84%, marking a year-over-year increase of 21100.0%. This contributed to the annual value of 9.21% for FY2024, which is 1300.0% down from last year.
  • As of Q3 2025, Quest Diagnostics' FCF Margin stood at 14.88%, which was up 48300.0% from 15.79% recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' FCF Margin peaked at 23.71% during Q1 2021, and registered a low of 1.42% during Q1 2023.
  • Its 5-year average for FCF Margin is 12.23%, with a median of 13.29% in 2022.
  • As far as peak fluctuations go, Quest Diagnostics' FCF Margin soared by 147100bps in 2021, and later plummeted by -173900bps in 2023.
  • Quest Diagnostics' FCF Margin (Quarter) stood at 12.28% in 2021, then tumbled by -35bps to 8.02% in 2022, then surged by 148bps to 19.89% in 2023, then crashed by -35bps to 13.01% in 2024, then grew by 14bps to 14.88% in 2025.
  • Its FCF Margin stands at 14.88% for Q3 2025, versus 15.79% for Q2 2025 and 7.43% for Q1 2025.